Optex Systems Holdings Inc quarterly report, Q3 FY2013

Optex Systems Holdings, Inc. — Q3 FY2013 Form 10-Q Summary

Business Context and Reporting Period

The filing covers the unaudited three and nine months ended June 30, 2013, compared with the three and nine months ended July 1, 2012. Optex manufactures optical sighting systems, periscopes, rifle and surveillance sights, night-vision assemblies, and related products primarily for U.S. Department of Defense, foreign military, and defense-prime customers. The company operated with 69 full-time equivalent employees in a leased 49,100-square-foot Richardson, Texas facility.

Key Financial Metrics

MetricQ3 FY2013Prior Comparable QuarterNine Months FY2013Prior Comparable Nine Months
Revenue$4.358 million$3.476 million$11.978 million$11.608 million
Gross profit$0.670 million$0.669 million$2.023 million$2.006 million
Gross margin15.2%19.1%16.7%17.2%
Operating income (loss)$(0.096) million$(0.118) million$(0.185) million$(0.102) million
Net income (loss) applicable to common shareholders$(0.079) million$(0.137) million$(0.145) million$(0.150) million
Basic and diluted loss per share$(0.00)$(0.00)$(0.00)$(0.00)

Cash flow and liquidity: Cash used in operating activities was $1.057 million for the nine months, principally due to a $1.097 million increase in inventory. Investing activities used $0.018 million, while financing activities provided $0.323 million from borrowings under the credit facility. Cash declined from $1.653 million at September 30, 2012 to $0.901 million at June 30, 2013.

Balance sheet and debt: Total assets were $12.382 million and total liabilities were $4.818 million at June 30, 2013. Net inventory increased to $8.191 million from $7.094 million at September 30, 2012. Accounts receivable declined to $1.543 million from $1.843 million. The Avidbank revolving credit facility had $0.323 million outstanding against capacity of up to $1.0 million; the facility maturity date was July 15, 2014, and borrowings generally bear interest at the greater of 7.0% or prime plus 3.5%.

Material Changes Versus Prior Comparable Period

  • Q3 revenue increased 25.7%, led by higher sighting-system and other-product shipments; periscope revenue declined 10.0% because lower glass-periscope demand offset growth in plastic periscopes.
  • Nine-month revenue increased 3.4%. Howitzer revenue fell $1.7 million following completion of the M137 program, while sighting systems increased 83.3% and other products increased 300.0%.
  • Gross profit was essentially flat in Q3 and increased modestly for the nine-month period, but gross margins declined because of a less profitable product mix.
  • Q3 operating loss improved by $0.022 million, while the nine-month operating loss increased by approximately $0.083 million, primarily from higher research and development and other general and administrative costs.
  • Q3 net loss applicable to common shareholders improved by $0.058 million, partly due to a favorable deferred-tax effect. Nine-month net loss was approximately unchanged from the prior period.
  • Backlog declined to $15.0 million at June 30, 2013 from $16.9 million at July 1, 2012, an 11.2% decrease. The company reported $8.0 million of new orders during the nine months.

Guidance, Outlook, Risks, Contingencies, and Unusual Items

  • Management expected Q4 periscope revenue to exceed the prior-year quarter and expected full-year periscope revenue to increase. It also expected higher sighting-system production under the five-year M36 contract and significant growth in other product lines.
  • Management expected FY2013 gross margins to improve in the final quarter and to be consistent with or slightly above the prior-year trend; no formal earnings or revenue guidance was provided.
  • The M36 contract was expected to generate approximately $1.1 million of FY2013 deliveries and approximately $1.6 million annually thereafter through completion, according to management.
  • Customer advance deposits totaled approximately $3.0 million at June 30, 2013, including approximately $2.9 million of unliquidated milestone invoices. The related contract extends through 2017 and requires future material purchases and product deliveries.
  • Optex appealed the rejection of an approximately $0.8 million equitable-adjustment claim related to Howitzer program design and manufacturability issues. An amended complaint was filed July 3, 2013, and alternative dispute resolution was under consideration. Resolution was expected to continue into the third quarter of fiscal 2014; success was not assured.
  • On July 11, 2013, after the reporting date, Optex acquired approximately $0.375 million of selected inventory, equipment, hand tools, and intellectual property from Miller-Holzwarth, Inc. as part of a combined $0.750 million auction bid.
  • Stock-based compensation expense was $0.119 million for the nine months, including $0.026 million related to early vesting of a former director’s options. Approximately 48.3 million options were outstanding, of which 17.7 million were vested, and 4.5 million warrants were outstanding at June 30, 2013.
  • Management stated that available resources and liquidity were sufficient for the next twelve months, but continued operating losses, inventory requirements, backlog levels, customer concentration, defense-program timing, and reliance on credit availability remain important risks.

Most Important Facts for Investors to Verify

  • Whether the elevated $8.2 million inventory balance converts to shipments and cash as projected.
  • The timing, profitability, and remaining delivery obligations under the M36 and other major defense contracts.
  • The status and ultimate recovery, if any, of the Howitzer equitable-adjustment claim.
  • Compliance with the Avidbank facility’s covenants, including the required 30-consecutive-day zero balance, and the facility’s renewal or maturity status.
  • The economic impact of the post-quarter Miller-Holzwarth asset acquisition.
  • The potential dilution from approximately 48.3 million outstanding stock options, 4.5 million warrants, and Series A preferred stock.
  • Whether management’s Q4 expectations for revenue growth and margin improvement were achieved.